NCI Explores AI to Screen For and Treat Pancreatic Cancer
The institute sees the emerging technology supporting treatment for patients by better controlling tumor growth.
A new initiative at the National Cancer Institute aims to create capabilities for detecting pancreatic cancer early and improving treatments for patients with mutations.
A big challenge with pancreatic cancer resides in the KRAS gene. When mutated, the gene can cause normal cells to become cancerous. A new therapy involving KRAS inhibitors and genetic testing can help patients screen for this earlier.
Dr. Christine Alewine, the NIH Lasker Scholar in the Laboratory of Molecular Biology at NCI’s Center for Cancer Research, discussed this breakthrough, how new advancements can serve as an alternative treatment for chemotherapy and where AI can make an impact. Plus, she notes how other health issues such as diabetes also plays a role in screening for pancreatic cancer.
-
Dr. Christine Alewine NIH Lasker Scholar in the Laboratory of Molecular Biology, Center for Cancer Research NCI
-
Pentagon Leaders Must Give ‘Top Cover’ for Risk-Taking, DOW Official Says
Bonnie Evangelista says acquisition reform will fail without leadership support that allows for experimentation without penalty.
3m read -
Digital GI Bill Automation Speeds VA Benefits Delivery
VA officials said Digital GI Bill upgrades have improved claims speed, enabling the department to process benefits with fewer staff.
3m read -
Who’s in Charge of AI at Every Federal Agency
New AI memos from the Trump administration prompt federal agencies to establish chief AI officers and OMB to launch a new CAIO AI Council.
7m read -
Federal CIO: ‘The Shackles are Off’ for AI Innovation in Government
Federal CIO Gregory Barbaccia said the PMA encourages faster tech adoption, AI experimentation and simpler digital services for citizens.
3m read
